Medications

The new insulin price cap: What you need to know

In early March, Eli Lilly made headlines after announcing a new $35 price cap on insulin for individuals with private insurance. Novo Nordisk and Sanofi made their own price reduction announcements shortly after Eli Lilly's ...

Diabetes

Liraglutide augments weight loss in pre-type 2 diabetes

(HealthDay)—For patients at high risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), liraglutide in additional to calorie restriction is associated with more weight loss and improvements in insulin ...

Overweight & Obesity

US FDA approves Wegovy to cut risk of heart problems

The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage.

Psychology & Psychiatry

Early MR scans found more people with broken-heart syndrome

In almost 10% of myocardial infarctions, no obvious cause in the coronary artery can be found. Some of the patients are diagnosed with broken-heart syndrome, while others are left without a diagnosis. A new study from Karolinska ...

page 4 from 15